The pharmaceutical consulting firm in medical technology and biotechnology Alira Health will create a hundred jobs in its Barcelona office in the next two years, thus doubling its current number of employees.
With this expansion, the Catalan subsidiary of the American company positions itself as one of the group's main workplaces, which employs a total of 600 people worldwide, including scientists, economists, and biostatisticians. The international team includes more than 350 scientists.
The firm, present in Catalonia since 2018 and with offices on Josep Tarradellas avenue in the Catalan capital, wants to incorporate technological profiles, health technology experts, digitalization experts, and developers, to strengthen its presence in the health sector. It is also interested in profiles with doctorates and experience in the healthcare field.
Alira Health specializes in integrated services designed to help life sciences and healthcare companies innovate and grow throughout the lifecycle of their solutions. With its work, it aims to merge the development of pharmaceutical, medical, and digital technologies with healthcare through a patient-centered approach. The company's clients range from small firms in the pharmaceutical sector to large internationalized companies.
In this regard, it values its positioning in Barcelona, which it considers a place "with a lot of research talent and for the quality of the pharmaceutical industry, hospitals, and education: being in Barcelona is a very easy way for talent to come and work at Alira Health," highlighted Nerea Blanqué, senior vice president of the consultancy.
The company, founded in 1999 by Benjamin Chambon and Gabriele Brambilla, has its main headquarters in Framingham (Massachusetts) and has offices in San Francisco, Toronto, Paris, Milan, Cambridge, and Munich, among others.
The company's co-founder, Benjamin Chambon, announced the expansion of the workforce during a visit by the Minister of Business, Roger Torrent, with whom they discussed various topics, including how to collaborate in relation to the European Next Generation funds, according to company sources.
The American group also acts as an incubator through Alira Health Ventures, which supports the growth of projects that research, develop, and bring new products to market in the healthcare and life sciences sector.